LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 868 | 1755 | 3486 | 0.5034 | 0.3387 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 868 | 1888 | 3486 | 0.5415 | 0.3895 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 868 | 1795 | 3486 | 0.5149 | 0.3540 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 1 | L15 | 72 | hr | 868 | 2591 | 3486 | 0.7432 | 0.6580 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 2 | L15 | 72 | hr | 868 | 2811 | 3486 | 0.8063 | 0.7421 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 3 | L15 | 72 | hr | 868 | 2741 | 3486 | 0.7862 | 0.7153 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 1 | B09 | 72 | hr | 868 | 2550 | 3486 | 0.7314 | 0.6424 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 2 | B09 | 72 | hr | 868 | 2694 | 3486 | 0.7727 | 0.6974 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 3 | B09 | 72 | hr | 868 | 2676 | 3486 | 0.7676 | 0.6905 |
MDA-MB-231 | SU11274 | 1.11 | uM | LJP5 | 1 | J09 | 72 | hr | 868 | 3194 | 3486 | 0.9161 | 0.8883 |
MDA-MB-231 | SU11274 | 1.11 | uM | LJP5 | 2 | J09 | 72 | hr | 868 | 3582 | 3486 | 1.0274 | 1.0365 |
MDA-MB-231 | SU11274 | 1.11 | uM | LJP5 | 3 | J09 | 72 | hr | 868 | 3406 | 3486 | 0.9769 | 0.9693 |
MDA-MB-231 | Fedratinib | 1.11 | uM | LJP5 | 1 | L03 | 72 | hr | 868 | 2134 | 3486 | 0.6121 | 0.4835 |
MDA-MB-231 | Fedratinib | 1.11 | uM | LJP5 | 2 | L03 | 72 | hr | 868 | 2230 | 3486 | 0.6396 | 0.5201 |
MDA-MB-231 | Fedratinib | 1.11 | uM | LJP5 | 3 | L03 | 72 | hr | 868 | 2417 | 3486 | 0.6933 | 0.5916 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 1 | H21 | 72 | hr | 868 | 2884 | 3486 | 0.8272 | 0.7699 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 2 | H21 | 72 | hr | 868 | 2973 | 3486 | 0.8527 | 0.8039 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 3 | H21 | 72 | hr | 868 | 2900 | 3486 | 0.8318 | 0.7760 |
MDA-MB-231 | Torin1 | 1.11 | uM | LJP6 | 1 | O15 | 72 | hr | 868 | 1363 | 3486 | 0.3910 | 0.1890 |
MDA-MB-231 | Torin1 | 1.11 | uM | LJP6 | 2 | O15 | 72 | hr | 868 | 1313 | 3486 | 0.3766 | 0.1699 |
MDA-MB-231 | Torin1 | 1.11 | uM | LJP6 | 3 | O15 | 72 | hr | 868 | 1293 | 3486 | 0.3709 | 0.1623 |
MDA-MB-231 | Torin2 | 1.11 | uM | LJP5 | 1 | I21 | 72 | hr | 868 | 966 | 3486 | 0.2771 | 0.0374 |
MDA-MB-231 | Torin2 | 1.11 | uM | LJP5 | 2 | I21 | 72 | hr | 868 | 1003 | 3486 | 0.2877 | 0.0515 |
MDA-MB-231 | Torin2 | 1.11 | uM | LJP5 | 3 | I21 | 72 | hr | 868 | 1145 | 3486 | 0.3284 | 0.1058 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 868 | 1064 | 3486 | 0.3052 | 0.0748 |